Inhibitory effects of the β2-adrenergic receptor agonist zilpaterol on the LPS-induced production of TNF-α in vitro and in vivo

Journal of Veterinary Pharmacology and Therapeutics

Volumn 28, Issue 6, 2005, Pages 531-537

  Verhoeckx, K C M ^a,b   Doornbos, R P ^a   Van Der Greef, J ^a,b   Witkamp, R F ^a   Rodenburg, R J T ^c  

^a TNO   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; ALPRENOLOL; ATENOLOL; BACTERIUM LIPOPOLYSACCHARIDE; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CLENBUTEROL; CYCLIC AMP; FORMOTEROL; ISOPRENALINE; PROPRANOLOL; SALBUTAMOL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ZILPATEROL;

ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CATTLE; CELL STRAIN U937; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG EFFECT; DRUG RECEPTOR BINDING; DRUG STRUCTURE; HUMAN; HUMAN CELL; INFLAMMATION; MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN;

ADRENERGIC BETA-AGONISTS; ANIMALS; CATTLE; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; ESCHERICHIA COLI; HUMANS; IMMUNOLOGIC FACTORS; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MALE; RATS; RATS, WISTAR; TRIMETHYLSILYL COMPOUNDS; TUMOR NECROSIS FACTOR-ALPHA; U937 CELLS;

ANIMALIA; BACTERIA (MICROORGANISMS); BOS TAURUS; RATTUS NORVEGICUS;

EID: 28444441014     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2005.00691.x     Document Type: Article

References (29)

1. Barnes, P.J. (1999) Effect of beta-agonists on inflammatory cells. Journal of Allergy and Clinical Immunology. 104, S10-S17.
2. Birkelo, C.P. (2003) Pharmaceuticals, direct-fed microbials, and enzymes for enhancing growth and feed efficiency of beef. Veterinary Clinics of North America. Food Animal Practice, 19, 599-624, vi.
3. Bocca, B., Di Mattia, M., Cartoni, C., Fiori, M., Felli, M., Neri, B. & Brambilla, G. (2003) Extraction, clean-up and gas chromatography-mass spectrometry characterization of zilpaterol as feed additive in fattening cattle. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 783, 141-149.
4. Diamant, Z. & Dekhuijzen, P.N.R. (2003) Behandeling van matig, persisterend astma: inhalatiecorticosteroiden combineren met langwerkende beta2adrenerge agonisten (luchtwegverwijders) dan wel met leukotrieenreceptoragonisten (ontstekingsremmers): het 'stap-3-dilemma'. Nederlands Tijdschrift voor Geneeskunde, 147, 1681-1685.
5. Goubault, C., Perault, M.C., Leleu, E., Bouquet, S., Legros, P., Vandel, B. & Denjean, A. (2001) Effects of inhaled salbutamol in exercising non-asthmatic athletes. Thorax, 56, 675-679.
6. Intervet (1998) Zilmax Technical Brochure. Intervet Inc., Millsboro, DE.
7. Izeboud, C.A., Monshouwer, M., van Miert, A.S. & Witkamp, R.F. (1999a) The beta-adrenoceptor agonist clenbuterol is a potent inhibitor of the LPS-induced production of TNF-alpha and IL-6 in vitro and in vivo. Inflammation Research, 48, 497-502.
8. Izeboud, C.A., Mocking, J.A., Monshouwer, M., van Miert, A.S. & Witkamp, R.F. (1999b) Participation of beta-adrenergic receptors on macrophages in modulation of EPS-induced cytokine release. Journal of Receptor and Signal Transduction Research, 19, 191-202.
9. Izeboud, C.A., Hoebe, K.H., Grootendorst, A.F., Nijmeijer, S.M., van Miert, A.S., Witkamp, R.R. & Rodenburg, R.J. (2004) Endotoxin-induced liver damage in rats is minimized by beta 2-adrenoceptor stimulation. Inflammation Research, 53, 93-99.
10. Ji, T.H., Grossmann, M. & Ji, I. (1998) G protein-coupled receptors. I. Diversity of receptor-ligand interactions. Journal of Biological Chemistry. 273, 17299-17302.
11. Johnson, M. (1993) Beta 2-agonists as anti-inflammatory therapies in the lung. Agents and Actions. Supplements, 41, 27-45.
12. Johnson, M. (2002) Effects of beta2-agonists on resident and infiltrating inflammatory cells. Journal of Allergy and Clinical Immunology, 110, S282-S290.
13. Kast, R.E. (2000) Tumor necrosis factor has positive and negative self regulatory feed back cycles centered around cAMP. International Journal of Immunopharmacology, 22, 1001-1006.
14. Liggett, S.B. (2002) Update on current concepts of the molecular basis of beta2-adrenergic receptor signaling. Journal of Allergy and Clinical Immunology, 110, S223-S227.
15. Lombardi, M.S., Kavelaars, A. & Heijnen, C.J. (2002) Role and modulation of G protein-coupled receptor signaling in inflammatory processes. Critical Reviews in Immunology, 22, 141-163.
16. Neer, E.J. (1994) G proteins: critical control points for transmembrane signals. Protein Science, 3, 3-14.
17. Nurnberg, B., Gudermann, T. & Schultz, G. (1995) Receptors and G proteins as primary components of transmembrane signal transduction. Part 2. G proteins: structure and function. Journal of Molecular Medicine, 73, 123-132.
18. Ricks, C.A., Dalrymple, R.H., Baker, P.K. & Ingle, D.L. (1984) Use of a beta-agonist to alter fat and muscle deposition in steers. Journal of Animal Science, 59, 1247-1255.
19. Sears, M.R. (1998) Asthma treatment: inhaled beta-agonists. Canadian Respiratory Journal, 5 (Suppl. A), 54A-59A.
20. Sekut, L., Champion, B.R., Page, K., Menius, J.A. Jr & Connolly, K.M. (1995) Anti-inflammatory activity of salmeterol: down-regulation of cytokine production. Clinical and Experimental Immunology, 99, 461-466.
21. Settipane, R.A. (2003) Defining the effects of an inhaled corticosteroid and long-acting beta-agonist on therapeutic targets. Allergy and Asthma Proceedings, 24, 85-89.
22. Severn, A., Rapson, N.T., Hunter, C.A. & Liew, F.Y. (1992) Regulation of tumor necrosis factor production by adrenaline and beta-adrenergic agonists. Journal of Immunology, 148, 3441-3445.
23. Shelver, W.L. & Smith, D.J. (2004) Enzyme-linked immunosorbent assay development for the beta-adrenergic agonist zilpaterol. Journal of Agricultural and Food Chemistry, 52, 2159-2166.
24. Spann, C. & Winter, M.E. (1995) Effect of clenbuterol on athletic performance. Annals of Pharmacotherapy, 29, 75-77.
25. Strosberg, A.D. (1993) Structure, function, and regulation of adrenergic receptors. Protein Science, 2, 1198-1209.
26. Sundstrom, C. & Nilsson, K. (1976) Establishment and characterization of a human histiocytic lymphoma cell line (U-937). International Journal of Cancer, 17, 565-577.
27. Torneke, K., Ingvast Larsson, C. & Appelgren, L.E. (1998) A comparison between clenbuterol, salbutamol and terbutaline in relation to receptor binding and in vitro relaxation of equine tracheal muscle. Journal of Veterinary Pharmacology and therapeutics, 21, 388-392.
28. Verhoeckx, K.C., Bijlsma, S., de Groene, E.M., Witkamp, R.F., van der Greef, J. & Rodenburg, R.J. (2004) A combination of proteomics, principal component analysis and transcriptomics is a powerful tool for the identification of biomarkers for macrophage maturation in the U937 cell line. Proteomics, 4, 1014-1028.
29. Zidek, Z. (1999) Adenosine - cyclic AMP pathways and cytokine expression. European Cytokine Network, 10, 319-328.